Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)
- A. HjalmarsonS. Goldstein L. Yellen
- 12 June 1999
Medicine
Glucose tolerance status and severity of coronary artery disease in men referred to coronary arteriography.
- M. SeibækC. Sloth P. Hildebrandt
- 1 June 1997
Medicine
Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria
- P. GædeP. Hildebrandt O. Pedersen
- 2004
Medicine
It is concluded that high plasma NT-proBNP is a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria.
Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen
- I. GustafssonP. Hildebrandt P. Kaiser-Nielsen
- 1 December 2000
Medicine
Patients with diabetes mellitus and myocardial infarction are treated with thrombolysis to a lesser extent than non-diabetic patients, but diabetic patients treated with oral hypoglycaemic agents or insulin, but not those treated with diet alone, have a significantly increased mortality following acute my Cardiac Infarction.
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial
- G. Torre-AmioneS. Anker James B. Young
- 19 January 2008
Medicine
Insulin resistance and maximal oxygen uptake
- M. SeibækH. Vestergaard Oluf Pedersen
- 1 November 2003
Medicine
Background: Type 2 diabetes, coronary atherosclerosis, and physical fitness all correlate with insulin resistance, but the relative importance of each component is unknown.
Patient adherence to evidence‐based pharmacotherapy in systolic heart failure and the transition of follow‐up from specialized heart failure outpatient clinics to primary care
- Anne GjesingM. Schou G. Gislason
- 1 June 2013
Medicine
Examination of long‐term adherence to and dosages of evidence‐based pharmacotherapy during and after participation in specialized HFCs for heart failure found no change in adherence or dosages.
The impact of heart failure on prognosis of diabetic and non‐diabetic patients with myocardial infarction: a 15‐year follow‐up study
- T. MelchiorC. Rask-MadsenC. Torp-PedersenP. HildebrandtL. KøberG. Jensen
- 1 January 2001
Medicine
Long term adherence in primary care versus a specialized heart failure clinic for outpatients with systolic heart failure
- M. SchouG. Gislason F. Gustafsson
- 1 August 2013
Medicine
Extended follow up in an outpatient HF clinic did not improve long-term adherence to guideline based therapy and adherence did not deteriorate when follow-up was shifted from the HF clinic to primary care and novel strategies to improve long term adherence for aldosterone receptor antagonists are needed.
...
...